![Arun Swaminathan](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Arun Swaminathan
Algemeen Directeur bij COYA THERAPEUTICS, INC.
Vermogen: 57 300 $ op 31-12-2024
Oorsprong van het eerstegraads netwerk van Arun Swaminathan
| Entiteit | Type entiteit | Industrie | |
|---|---|---|---|
| Public Company | Biotechnology | 13 | |
| Public Company | Biotechnology | 8 | |
| Public Company | Pharmaceuticals: Major | 6 |
Grafiek van bedrijven verbonden in de tweede graad
Connectie in verschillende bedrijven
Bedrijven verbonden met Arun Swaminathan via zijn persoonlijke netwerk
| Onderneming | Sector | Gelieerde personen | Hoofdpost |
|---|---|---|---|
| BRISTOL-MYERS SQUIBB COMPANY | Pharmaceuticals: Major | President Corporate Officer/Principal Corporate Officer/Principal | |
| Korea University | College/University | Doctorate Degree Doctorate Degree Graduate Degree | |
| Seoul National University | College/University | Graduate Degree Graduate Degree Undergraduate Degree | |
| PFIZER, INC. | Pharmaceuticals: Major | Corporate Officer/Principal Corporate Officer/Principal | |
| Stanford University | College/University | Undergraduate Degree Corporate Officer/Principal | |
| Harvard Business School | College/University | Masters Business Admin Masters Business Admin | |
| Yale University | College/University | Undergraduate Degree Doctorate Degree | |
| University of Michigan | College/University | Undergraduate Degree Masters Business Admin | |
Genentech, Inc.
 Genentech, Inc. Pharmaceuticals: MajorHealth Technology Genentech, Inc. develops, manufactures and markets pharmaceutical products for life-threatening medical conditions. It studies various areas including oncology, immunology, neuroscience, ophthalmic diseases, microbial pathogenesis, metabolic diseases, cardiovascular diseases, and opportunistic areas. The company was founded by Herb W. Boyer and Robert A. Swanson in 1976 and is headquartered in South San Francisco, CA. | Pharmaceuticals: Major | Corporate Officer/Principal Corporate Officer/Principal | |
Reunion Neuroscience, Inc.
 Reunion Neuroscience, Inc. BiotechnologyHealth Technology Reunion Neuroscience, Inc. engages in operating the drug discovery and development business. Its novel psychedelic drug development, committed to innovating therapeutic solutions for mental health conditions by developing proprietary serotonin receptor agonist compounds. The company was founded on September 30, 2008 and is headquartered in Toronto, Canada. | Biotechnology | Director/Board Member Director/Board Member | |
| UCB BioSciences, Inc. | Corporate Officer/Principal | ||
| EAGLE PHARMACEUTICALS, INC. | Pharmaceuticals: Major | Chief Tech/Sci/R&D Officer | |
| Universidad de Buenos Aires | College/University | Doctorate Degree | |
| PHARNEXT SCA | Biotechnology | Chief Tech/Sci/R&D Officer | |
| BIODELIVERY SCIENCES INTERNATIONAL, INC. | Pharmaceuticals: Major | Chief Tech/Sci/R&D Officer | |
| AVANIR PHARMACEUTICALS INC | Pharmaceuticals: Major | Chief Tech/Sci/R&D Officer | |
BNH Investment LLC
 BNH Investment LLC Investment ManagersFinance BNH Investment LLC (BNH Invest) is an independent venture capital firm headquartered in Seoul, Korea. The firm is established in 2014. | Investment Managers | Private Equity Investor | |
Innopolis Partners LLC
 Innopolis Partners LLC Investment ManagersFinance Innopolis Partners LLC (Innopolis Partners) is a venture capital firm founded in 2006 by Dong-won Park, Sang-jin Lee, Nam-hoon Cho, Moon-hwan Park and Seok-hoon Lee. The firm is headquartered in Seoul, South Korea. | Investment Managers | Founder | |
| GENPREX, INC. | Pharmaceuticals: Major | Chief Tech/Sci/R&D Officer | |
| ADVANCED NANO PRODUCTS CO., LTD. | Chemicals: Specialty | Comptroller/Controller/Auditor | |
| EDGE FOUNDRY CO.,LTD | Automotive Aftermarket | Comptroller/Controller/Auditor | |
| Hanbat National University | College/University | Corporate Officer/Principal | |
Deciphera Pharmaceuticals LLC
 Deciphera Pharmaceuticals LLC BiotechnologyHealth Technology Deciphera Pharmaceuticals LLC discovers and develops pharmaceutical preparations. It designs kinase inhibitor therapies that target the hallmarks of cancer biology. The firm’s clinical pipeline of kinase inhibitors includes tumor-targeted therapies and immuno-targeted therapies. It offers DCC-2618, Rebastinib, and DCC-3014. The company was founded by Daniel L. Flynn in 2003 and is headquartered in Waltham, MA. | Biotechnology | Chief Tech/Sci/R&D Officer | |
| University of Calgary | College/University | Doctorate Degree | |
| Kangwon National University | College/University | Corporate Officer/Principal | |
| YUHAN CORPORATION | Pharmaceuticals: Major | Director/Board Member | |
HealthPrize Technologies LLC
 HealthPrize Technologies LLC Packaged SoftwareTechnology Services HealthPrize Technologies LLC provides medication adherence solutions for patients. It offers digital platform that improves medication adherence via combination of education and rewards. The company was founded by Thomas Kottler, Katrina Firlik and James Jorasch in September 2009 and is headquartered in Norwalk, CT. | Packaged Software | Director/Board Member | |
Bayer Pharma AG
 Bayer Pharma AG Pharmaceuticals: MajorHealth Technology Bayer Pharma AG engages in the development and production of prescription drugs for the treatment of cardiovascular diseases and women's illnesses, as well as special therapy in the areas of oncology, hematology, and ophthalmology. It also offers medical equipment used in diagnostic imaging with applications in the field of radiology. The company was founded on March 9, 1965 and is headquartered in Berlin, Germany. | Pharmaceuticals: Major | Chief Executive Officer | |
| BAYER AG | Pharmaceuticals: Major | Director/Board Member | |
Otsuka Pharmaceutical Development & Commercialization, Inc.
 Otsuka Pharmaceutical Development & Commercialization, Inc. Pharmaceuticals: MajorHealth Technology Part of Otsuka Holdings Co., Ltd., Otsuka Pharmaceutical Development & Commercialization, Inc. is a healthcare company that was founded in 2007. The company is based in Princeton, NJ. The company is driven by their purpose and defined by their beliefs. | Pharmaceuticals: Major | Corporate Officer/Principal | |
| Long Island University | College/University | Graduate Degree | |
| Concordia College (New York) | College/University | Undergraduate Degree | |
| REPLIMUNE GROUP, INC. | Biotechnology | Director/Board Member | |
| Bayer Pharmaceuticals Corp. | President | ||
Otsuka Pharmaceutical Co., Ltd.
 Otsuka Pharmaceutical Co., Ltd. Pharmaceuticals: MajorHealth Technology Otsuka Pharmaceutical Co. Ltd. engages in the manufacturing, distributing, exporting, and importing of pharmaceuticals, clinical testing equipment, medical device and equipment, food products, cosmetics, and other related products. Its operations are carried out through the following business divisions: Pharmaceutical Business and Nutraceutical Business. The Pharmaceutical Business division engages in the manufacture and sale of pharmaceutical products for the diagnosis and treatment of diseases. The Nutraceutical Business division provides nutritional products, cosmetics and medicines that support day-to-day health maintenance and improvement. The company was founded on August 10, 1964 and is headquartered in Tokyo, Japan. | Pharmaceuticals: Major | Corporate Officer/Principal | |
| The University of Virginia School of Medicine | College/University | Doctorate Degree | |
W.L. Ross & Co. LLC
 W.L. Ross & Co. LLC Investment ManagersFinance W.L. Ross & Co. LLC (WL Ross & Co) is a private equity subsidiary of Invesco Ltd. founded in 2000 by Wilbur Louis Ross. The firm is headquartered in New York. | Investment Managers | Chief Executive Officer | |
Kadmon Corp. LLC
 Kadmon Corp. LLC Pharmaceuticals: MajorHealth Technology Kadmon Corp. LLC manufactures and distributes pharmaceutical products. It currently offers products and services for the treatment and management of hepatitis C, is pioneering medicines in oncology, infectious diseases, and immunology and neurodegenerative diseases by using new understandings in molecular biology to develop therapies that target the metabolomic and signaling pathways associated with disease. The company was founded in 2009 and is headquartered in New York, NY. | Pharmaceuticals: Major | Chief Tech/Sci/R&D Officer | |
DisperSol Technologies LLC
 DisperSol Technologies LLC Pharmaceuticals: MajorHealth Technology DisperSol Technologies LLC offers plastics processing technology to pharmaceutical manufacturing companies. It offers KinetiSol, a pharmaceutical processing technology that provides solutions to oral drug delivery problems and for amorphous solid dispersion systems; and ArmoRx Platform, a processing technology that enables use of certain compendial pharmaceutical polymers to produce oral dosage forms that are inherently abuse deterrent. The company was founded by Gershon Yaniv in 2007 and is headquartered in Georgetown, TX. | Pharmaceuticals: Major | Director of Finance/CFO | |
RIGImmune, Inc.
 RIGImmune, Inc. Miscellaneous Commercial ServicesCommercial Services RIGImmune, Inc. is a biopharmaceutical company based in Farmington, CT. RIGImmune, Inc. is focused on developing a new class of immune-modulating therapies, specifically RNA therapeutics, to prevent or treat serious respiratory diseases. RIGImmune's lead product candidate is Rig-101, a stem loop RNA therapeutic that enhances the innate immune response against viral respiratory diseases. The company also has a second product candidate, Rig-301, which targets the CFTR mutation in cystic fibrosis patients. RIGImmune has developed a proprietary nano-emulsion delivery technology platform called NEED™ to effectively deliver RNA compounds without the need for lipid nanoparticle encapsulation. The company has subsidiaries in the UK. RIGImmune was founded in 2020 by Akiko Iwasaki and Anna Marie Pyle, prominent scientists from Yale University. The CEO of the company is Martin J. Driscoll. | Miscellaneous Commercial Services | Chief Executive Officer | |
| BIOAGE LABS, INC. | Biotechnology | Director of Finance/CFO | |
RCMC Capital LLP
 RCMC Capital LLP Financial ConglomeratesFinance Part of RCMA Services (UK) Ltd., RCMC Capital LLP is a private limited partnership based in London, UK. RCMC Capital is authorised and regulated by the FCA as an alternative investment fund manager and is also registered with the Commodities and Futures Trading Commission as a commodity pool operator. The British company provides general information about their services on their website, but it is not intended for public use or distribution. Investors should independently verify and check the accuracy, completeness, reliability, and suitability of the information before making any investment decision. The information contained on the webpage does not constitute financial, investment, legal, accounting, tax, or other professional advice or a solicitation for investment in RCMA's funds. The company was founded in 2004 and Douglas King has been the CEO of the company since 2004. | Financial Conglomerates | Corporate Officer/Principal | |
CompassCare, Inc.
 CompassCare, Inc. Information Technology ServicesTechnology Services CompassCare, Inc. provides healthcare information technology services. The company provides practice management system that includes an EMR that delivers invoices faster, reduces payment cycles, and increases the efficiency of case management and claim adjudication. It was founded in 2001 and is headquartered in Bannockburn, IL | Information Technology Services | Director of Finance/CFO | |
| University of Ottawa | College/University | Undergraduate Degree | |
| CELLULAR DYNAMICS INTERNATIONAL INC | Biotechnology | Director of Finance/CFO | |
Cobalt Group, Inc.
 Cobalt Group, Inc. Advertising/Marketing ServicesCommercial Services Cobalt Group, Inc. provides web-based marketing services. The company was founded in 1995 and is headquartered in Seattle, WA. | Advertising/Marketing Services | Director of Finance/CFO | |
Roche NimbleGen, Inc.
 Roche NimbleGen, Inc. Miscellaneous Commercial ServicesCommercial Services Roche NimbleGen, Inc. provides products and services to the life science research market. The private company is based in Madison, WI. Frank Pitzer has been the CEO of the company since 2010. | Miscellaneous Commercial Services | Director of Finance/CFO | |
MCC Holdings, Inc.
 MCC Holdings, Inc. Industrial MachineryProducer Manufacturing MCC Holdings, Inc. manufactures and sells industrial valves. The company was registered in September 3, 1987 and is headquartered in Stamford, CT. | Industrial Machinery | Director of Finance/CFO |
Statistieken
Internationaal
| Verenigde Staten | 32 |
| Zuid-Korea | 10 |
| Canada | 4 |
| Duitsland | 3 |
| Argentinië | 2 |
Sectoraal
| Health Technology | 22 |
| Consumer Services | 15 |
| Finance | 5 |
| Commercial Services | 4 |
| Technology Services | 3 |
Operationeel
| Director/Board Member | 122 |
| Chairman | 47 |
| Corporate Officer/Principal | 46 |
| Independent Dir/Board Member | 28 |
| Chief Tech/Sci/R&D Officer | 26 |
Sterkste connecties
| Insiders | |
|---|---|
| Wilbur Ross | 115 |
| Dieter Weinand | 32 |
| Dov Goldstein | 28 |
| David Snyder | 15 |
| Ann Lee | 15 |
| Fred Grossman | 10 |
| Mark Berger | 10 |
| Hideki Garren | 9 |
| Adrian Hepner | 7 |
| Monideepa Roy | 6 |
| Caroline Yarbrough | 5 |
| Howard Berman | 5 |
| Anabella Villalobos | 5 |
| In-Young Go | 5 |
| Jong-In Choi | 5 |
- Beurs
- Insiders
- Arun Swaminathan
- Bedrijfsconnecties
